A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to help determine whether β-elemene as maintain treatment for
complete remission patients of newly diagnosed malignant gliomas following standard
treatment, is able to delay tumor growth, or impact how long people with newly diagnosed
high-grade glioma.